Snakebite envenomations and access to treatment in communities of two indigenous areas of the Western Brazilian Amazon: A cross-sectional study.
Journal
PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488
Informations de publication
Date de publication:
07 2023
07 2023
Historique:
received:
17
03
2023
accepted:
27
06
2023
revised:
25
07
2023
medline:
26
7
2023
pubmed:
13
7
2023
entrez:
13
7
2023
Statut:
epublish
Résumé
The indigenous populations of Brazil present poor health indicators and a disproportionate prevalence and case-fatality rate of neglected tropical diseases, including snakebite envenomations (SBEs). This study aims to estimate access to medical care for SBEs and analyze the barriers that prevent victims from accessing healthcare in indigenous communities in two health districts located in the Western Brazilian Amazon. This cross-sectional study used semi-structured interviews to collect data from individuals who experienced SBEs in the Upper Rio Solimões and Upper Rio Negro indigenous health districts. Of the 187 participants, 164 (87.7%) reported that they had access to healthcare and received assistance in a hospital in the urban area of the municipalities. Frequency was 95.4% in the Upper Rio Solimões SIHD, and 69.6% in the Upper Rio Negro SIHD (P<0.0001). The study found that the availability of indigenous medicine as the only choice in the village was the main reason for not accessing healthcare (75%), followed by a lack of financial resources and means of transportation (28.1%). Four deaths were reported from SBEs, resulting in a case-fatality rate of 2.1%. In the study areas, there are records of SBE patients who did not receive medical attention. Availability of pre-hospital emergency transport using motorboats, a greater number of hospitals and better navigability of the Solimões River and its tributaries would make access easier for indigenous people living in the region of the Upper Solimões River. The implementation of cross-cultural hospital care needs to be considered in order to reduce the resistance of indigenous populations in relation to seeking treatment for SBEs.
Sections du résumé
BACKGROUND
The indigenous populations of Brazil present poor health indicators and a disproportionate prevalence and case-fatality rate of neglected tropical diseases, including snakebite envenomations (SBEs). This study aims to estimate access to medical care for SBEs and analyze the barriers that prevent victims from accessing healthcare in indigenous communities in two health districts located in the Western Brazilian Amazon.
METHODOLOGY/PRINCIPAL FINDINGS
This cross-sectional study used semi-structured interviews to collect data from individuals who experienced SBEs in the Upper Rio Solimões and Upper Rio Negro indigenous health districts. Of the 187 participants, 164 (87.7%) reported that they had access to healthcare and received assistance in a hospital in the urban area of the municipalities. Frequency was 95.4% in the Upper Rio Solimões SIHD, and 69.6% in the Upper Rio Negro SIHD (P<0.0001). The study found that the availability of indigenous medicine as the only choice in the village was the main reason for not accessing healthcare (75%), followed by a lack of financial resources and means of transportation (28.1%). Four deaths were reported from SBEs, resulting in a case-fatality rate of 2.1%.
CONCLUSIONS/SIGNIFICANCE
In the study areas, there are records of SBE patients who did not receive medical attention. Availability of pre-hospital emergency transport using motorboats, a greater number of hospitals and better navigability of the Solimões River and its tributaries would make access easier for indigenous people living in the region of the Upper Solimões River. The implementation of cross-cultural hospital care needs to be considered in order to reduce the resistance of indigenous populations in relation to seeking treatment for SBEs.
Identifiants
pubmed: 37440596
doi: 10.1371/journal.pntd.0011485
pii: PNTD-D-23-00351
pmc: PMC10368234
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0011485Informations de copyright
Copyright: © 2023 de Farias et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Rev Soc Bras Med Trop. 2017 Jan-Feb;50(1):61-66
pubmed: 28327803
Toxins (Basel). 2020 Dec 05;12(12):
pubmed: 33291444
Int Health. 2023 Mar 1;15(2):216-223
pubmed: 35896028
Toxicon. 2018 Sep 1;151:15-23
pubmed: 29908262
Rev Panam Salud Publica. 2013 Jan;33(1):22-9
pubmed: 23440154
Ophthalmic Epidemiol. 2016 Dec;23(6):354-359
pubmed: 27142891
PLoS Negl Trop Dis. 2021 Sep 9;15(9):e0009758
pubmed: 34499643
PLoS One. 2020 Oct 21;15(10):e0240741
pubmed: 33085704
Toxicon. 2019 Dec 5;171:66-77
pubmed: 31628968
PLoS One. 2015 Jul 13;10(7):e0132237
pubmed: 26168155
Rev Soc Bras Med Trop. 2015;48 Suppl 1:42-54
pubmed: 26061370
J Trop Pediatr. 2023 Feb 6;69(2):
pubmed: 36795080
Cad Saude Publica. 2009 May;25(5):972-84
pubmed: 19488482
J Ethnopharmacol. 2011 Apr 12;134(3):739-52
pubmed: 21295130
PLoS Negl Trop Dis. 2020 Nov 30;14(11):e0008793
pubmed: 33253152
PLoS One. 2022 Jan 7;17(1):e0262215
pubmed: 34995326
Arch Dis Child. 2021 Jan;106(1):14-19
pubmed: 33115713
Toxicon. 2018 Apr;145:15-24
pubmed: 29490236
Toxins (Basel). 2023 Mar 03;15(3):
pubmed: 36977085
PLoS Negl Trop Dis. 2020 Aug 3;14(8):e0008445
pubmed: 32745113
Epidemiol Serv Saude. 2016 Jan-Mar;25(1):127-136
pubmed: 27861685
PLoS Negl Trop Dis. 2021 Mar 4;15(3):e0009245
pubmed: 33661895
Toxicon X. 2022 Sep 16;16:100137
pubmed: 36160931
PLoS Negl Trop Dis. 2023 Mar 10;17(3):e0011172
pubmed: 36897928